drugset / Trial / NCT04640545
A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma
NaSingle-groupOpen-labelTreatment
Summary
A phase I clinical study evaluating LBL-007 in the treatment of subjects with advanced solid tumors
Timeline
- Start
- 2020-05-12
- Primary completion
- 2024-08-19
- Completion
- 2024-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | — | — |
| Subject | LBL-007 | Unknown | — | Intravenous |
| Subject | Toripalimab | Monoclonal antibody | — | Intravenous |